Skip to content

Anti-PR (Progesterone Receptor)

by DB Biotech, a.s. Slovakia EUDAMED

Ref DB 109-RTU-7, DB 109-0.2, DB 109-1, DB 109-RTU-15, DB 109-0.1Model DB 109 EMDN W01030705

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number85850389DB109L3 Basic UDI-DIDate25 Mar 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
DB 109, DB 109-RTU-7, DB 109-0.2, DB 109-1, DB 109-RTU-15, DB 109-0.1
Primary DI / UDI-DI
08585038902707, 08585038902660, 08585038902684, 08585038902691, 08585038902653
Basic UDI-DI
85850389DB109L3
EMDN Code
W01030705 Fixing reagents (histology/cytology)
Device Class
Class C
Market of Registration
Slovakia

Manufacturer details

EUDAMED SRN
SK-MF-000051838

Other devices from DB Biotech, a.s.

See all devices from DB Biotech, a.s. →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (5)

  • EUDAMED ad539904-c285-42e7-867d-723cca93c9bd 61 fields · synced 22 Oct 2026
  • EUDAMED 08585038902660|85850389DB109L3 61 fields · synced 18 May 2026
  • EUDAMED 08585038902684|85850389DB109L3 61 fields · synced 18 May 2026
  • EUDAMED 08585038902691|85850389DB109L3 61 fields · synced 18 May 2026
  • EUDAMED 08585038902653|85850389DB109L3 61 fields · synced 19 May 2026